• 대한약침학회지
• /
• 제17권4호
• /
• pp.70-75
• /
• 2014

Objectives: The purpose of this study is to report the clinical effect of Korean medicine (KM) treatment for Henoch-Schonlein purpura (HSP). Methods: Five HSP patients who demonstrated a Yin deficiency and who had a history of a previous upper respiratory tract infection were included in this study. Four patients had arthritis and three had severe stomachache. One of them appeared to have proteinuria and hematuria before starting KM treatment. Results: All patients were improved with only herbal medicine, Jarotang (JRT). Purpura in the lower extremities and abdominal pain, which were not treated by using a corticosteroid, disappeared and had not recurred after 6 months. Conclusion: These cases indicate that JRT may be effective in treating HSP in patients who demonstrate Yin deficiency, even though the number of cases was limited to five.

• Tuberculosis and Respiratory Diseases
• /
• 제44권4호
• /
• pp.930-934
• /
• 1997

저자들은 RF, PZA, Cipro. 에 의하여 발생한 것으로 추정되는 혈소판 감소증과 자반증이 나타난 환자 1예를 경험하였기에 문한 고찰과 함께 보고하는바이다.

• 동의생리병리학회지
• /
• 제19권3호
• /
• pp.821-825
• /
• 2005

A boy who was eight years old visited the Dept. of Oriental Medical Ophthamology & Otolaryngology & Dermatology Hospital, Dongeui University with allergic purpura. He was suffering from the purpuric rash occurring on the lower extremities and the edema of leg. We treated a patient with only Oriental Medicine(a internal use of the herbal medicine, Dangguisusangamibang and a acupuncture). After four days or so, the symptom of the skin disease was recovered remarkably. The second case, a different boy who was ten years old visited the same hospital with allergic purpura. He was suffering from the purpuric rash occurring on the lower extremities, too. We also treated a patient with only Oriental Medicine(internal use of the herbal medicine, Dangguisusangamibang and a acupuncture). After one weeks or so, the symptom of the skin disease was improved remarkably, we think that these are good cases to treat with Oriental Medicine, Dangguisusangamibang. We suggest that the Oriental Herb medicine, Dangguisusangamibang have an effect with allergic purpura which means Podoyug in Oriental medicine.

• Advances in pediatric surgery
• /
• 제6권1호
• /
• pp.45-49
• /
• 2000

Henoch-Sch$\ddot{o}$nlein purpura is a systemic vasculitis of unknown etiology that is probably related to an autoimmune phenomenon. Henoch-Sch$\ddot{o}$nlein purpura is characterized by a purpuric rash, arthralgia, nephritis, and gastrointestinal manifestations. We reviewed 169 children hospitalized with a diagnosis of Henoch-Sch$\ddot{o}$nlein purpura between 1989 and 1998. One-hundred thirty-nine (82.2 %) had gastrointestinal findings including abdominal pain, nausea, vomiting and gastrointestinal bleeding. Surgical consultations were obtained for ten children, and laparotomy was performed in five. Three children suspected of having appendicitis underwent appendectomy. None had appendicitis. One child thought to have been intestinal strangulation was found to have hemorrhagic edema of the proximal jejunum and of the distal ileum. Another child underwent resection for an hemorrhagic infarct of the distal ileum. A high index of suspicion of this disease entity in the differential diagnosis of abdominal pain in children can avoid unnecessary laparotomy in most cases. However, life-threatening gastrointestinal complications may occur in low percentage of cases. Prompt recognition and adequate radiologic evaluation of the abdominal manifestation of this entity is necessary for early surgical intervention.

• 대한족부족관절학회지
• /
• 제26권1호
• /
• pp.48-53
• /
• 2022

The current SARS-CoV-2 coronavirus disease 2019 (COVID-19) pandemic has been a particular challenge for diabetes patients. Since these patients are at a higher risk of COVID-19, they have been prioritized for vaccination. In this report, we describe the case of a patient scheduled for diabetic foot amputation who received the first dose of ChAdOx1 nCov-19 vaccine and subsequently developed severe purpura in his genitalia and both of his hands and feet, accompanied by acute renal failure. The operation had to be postponed as severe limb purpura appeared just before the operation. With adequate management for acute renal failure and topical steroid application for the severe purpura lesions, a successful outcome could be obtained after the delayed first ray amputation. We recommend that COVID-19 vaccination should be carefully administered in patients with a diabetic foot requiring amputation.

• Clinical and Experimental Vaccine Research
• /
• 제13권2호
• /
• pp.166-170
• /
• 2024

The coronavirus disease 2019 (COVID-19) vaccine was developed to provide immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in 2019. The vaccine has proven to be effective in reducing severity and mortality and preventing infection. Henoch-Schönlein purpura is an autoimmune vasculitis (immunoglobulin A vasculitis). Historically, vaccines have been administered primarily to children, and Henoch-Schönlein purpura has often been reported in children following vaccination. However, since the start of COVID-19 vaccination, an increasing number of cases have been reported in adults. Here, we report a case of a patient who developed hematuria and proteinuria after receiving the messenger RNA COVID-19 vaccine. A 22-year-old man presented to the hospital with a lower extremity rash, bilateral ankle pain, and abdominal pain 18 days after receiving the COVID-19 vaccine. The man had no significant medical history and was not taking any medications. Laboratory tests showed normal platelet counts but elevated white blood cell counts and C-reactive protein and fibrinogen levels. He was treated with the non-steroidal anti-inflammatory drugs, pheniramine and prednisolone. At 40 days after starting treatment, C-reactive protein levels were within normal limits, and no hematuria was observed. Treatment was terminated when the purpura disappeared. This report is intended to highlight the need for further research to be proactive and carefully monitor for conditions associated with the COVID-19 vaccine.

• 한국임상약학회지
• /
• 제21권1호
• /
• pp.39-42
• /
• 2011

Idiopathic thrombocytopenic purpura is a potentially life-threatening condition characterised by thrombocytopenia and mediated by an autoimmune mechanism. Several recent studies have suggested that an association exists between H. pylori eradication and improvement in platelet count in a significant proportion of patients with idiopathic thrombocytopenic purpura. This study confirmed the efficacy of H. pylori eradication in increasing the platelet count in steroid refractory idiopathic thrombocytopenic purpura patients. Eradication therapy is simple and inexpensive, with limited toxicity and the advantage of avoiding long-term immunosuppressive treatment.

• Childhood Kidney Diseases
• /
• 제1권1호
• /
• pp.82-85
• /
• 1997

The incidence of nephritis associated with Henoch-Sch nlein purpura varies, but glomerulonephritis consistently accounts for most of the associated morbidity and mortality. A very small number of Henoch-Sch nlein purpura develop rapidly progressive glomerulonephritis. A three-year old male patient who showed acute nephritic nephrotic syndrome developed abdominal pain, arthralgia and multiple purpurae on lower extremities later. Peritoneal dialysis was done at the 6th hospital day and continued for 7 months. Renal biopsy disclosed crescentic glomerulonephritis (with 81% crescent formation) and methylprednisolone pulse therapy was done. These days, his general condition is good, but serum creatinine levels are 1.2-1.3 mg/dL. This case was reviewed briefly with the literatures.

• Tuberculosis and Respiratory Diseases
• /
• 제43권3호
• /
• pp.461-466
• /
• 1996

Diffuse alveolar hemorrhage is a very rare manifestation in Henoch-Schoenlein purpura. Recently we experience a case of diffuse alveolar hemorrhage associated with Henoch-Schoenlein purpura which was diagnosed by typical clinical manifestation and renal biopsy. A 25 year old male was admitted due to hemoptysis and dyspnea. Chest X-ray, HRCT and BAL revealed diffuse alveolar hemorrhage. He also had a history of skin rash, polyarthralgia, and hematochezia with abdominal pain. Renal biopsy which was taken for the evaluation of microscopic hematuria showed IgA nephropathy. Under the diagnosis of Henoch-Schoenlein purpura, we treated him with solumedrol pulse therapy, plasma-pheresis and prednisolone with cytoxan. After then he showed marked improvement in clinical manifestation and was discharged with prednisolone and cytoxan.

• Tuberculosis and Respiratory Diseases
• /
• 제65권2호
• /
• pp.116-120
• /
• 2008

Henoch-$Sh{\ddot{o}}nlein$ 자반증은 신장, 피부, 관절, 소화기계 등의 전신을 침범하는 혈관염으로 임상적인 증상을 종합하여 진단하는 질환이며 피부나 신장에서의 조직학적 생검이 진단을 뒷받침해 주는 근거가 될 수 있다. 항결핵제 사용 중에 rifampin으로 인하여 신기능 저하, 관절 통증, 양하지 자반, 복통 등의 임상 양상이 발생하였으며 하지 피부 병변의 조직 검사로 백혈구파쇄성혈관염(leukocytoclastic vasculitis) 소견을 보여 임상적으로 Henoch-$Sh{\ddot{o}}nlein$ 자반증으로 진단하였으며 rifampin 복용 중지 후 피부 자반 소실되고, 신장 기능이 회복된 예를 문헌 고찰과 함께 보고하는 바이다.